首页> 外国专利> BLOCKING AGENT OF WITHDRAWAL SYNDROME THAT IS A RESULT OF DRUG HABITUATION TO OVER INTAKING DRUGS AND SUBSTANCES CAUSING HABITUATION, PHARMACOLOGICAL COMPOSITION BASED ON THEREOF AND A METHOD OF RELIEF OR PREVENTION OF WITHDRAWAL SYNDROME

BLOCKING AGENT OF WITHDRAWAL SYNDROME THAT IS A RESULT OF DRUG HABITUATION TO OVER INTAKING DRUGS AND SUBSTANCES CAUSING HABITUATION, PHARMACOLOGICAL COMPOSITION BASED ON THEREOF AND A METHOD OF RELIEF OR PREVENTION OF WITHDRAWAL SYNDROME

机译:戒断综合征的阻塞剂,是药物过量摄入引起的药物滥用和造成该物质的物质,基于其的药理组成以及缓解或预防药物滥用综合征的方法

摘要

FIELD: medicine. SUBSTANCE: invention relates to the use of amperozid or its pharmaceutically acceptable salt by oral or parenteral route at daily dose 0.1-40 mg. Dose is administrated for time depending on syndrome severity. EFFECT: enhanced effectiveness of agent. 3 cl
机译:领域:医学。物质:本发明涉及通过口服或肠胃外途径以每日剂量0.1-40mg使用安非他酮或其药学上可接受的盐。根据综合征的严重程度,按时间服用剂量。效果:增强了药剂的效力。 3厘升

著录项

  • 公开/公告号RU2095062C1

    专利类型

  • 公开/公告日1997-11-10

    原文格式PDF

  • 申请/专利权人 KABI FARMATSIA AB (SE);

    申请/专利号RU19920016400

  • 发明设计人 ANDERS BERKSE;EHRIK KRISTENSSONSE;

    申请日1992-03-23

  • 分类号A61K31/495;

  • 国家 RU

  • 入库时间 2022-08-22 03:15:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号